載入...

In Vitro Development of Resistance to Telithromycin (HMR 3647), Four Macrolides, Clindamycin, and Pristinamycin in Streptococcus pneumoniae

The ability of 50 sequential subcultures in subinhibitory concentrations of telithromycin (HMR 3647), azithromycin, clarithromycin, erythromycin A, roxithromycin, clindamycin, and pristinamycin to select for resistance was studied in five macrolide-susceptible and six macrolide-resistant pneumococci...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Davies, Todd A., Dewasse, Bonifacio E., Jacobs, Michael R., Appelbaum, Peter C.
格式: Artigo
語言:en
出版: American Society for Microbiology 2000
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC89694/
https://ncbi.nlm.nih.gov/pubmed/10639373
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
實物特徵
總結:The ability of 50 sequential subcultures in subinhibitory concentrations of telithromycin (HMR 3647), azithromycin, clarithromycin, erythromycin A, roxithromycin, clindamycin, and pristinamycin to select for resistance was studied in five macrolide-susceptible and six macrolide-resistant pneumococci containing mefE or ermB. Telithromycin selected for resistance less often than the other drugs.